Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Accenture
Chinese Patent Office
Daiichi Sankyo
AstraZeneca
Colorcon
Citi
Medtronic
Johnson and Johnson

Generated: December 12, 2018

DrugPatentWatch Database Preview

LEUKINE Drug Profile

« Back to Dashboard

Summary for Tradename: LEUKINE

US Patents for LEUKINE

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up Bayer Intellectual Property GMBH (Monheim, DE) ➤ Sign Up RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up EnBio Limited (Dublin, IE) ➤ Sign Up RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up ➤ Sign Up RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up GENMAB A/S (Copenhagen V, DK) ➤ Sign Up RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up Bayer Pharma Aktiengesellshaft (Berlin, DE) ➤ Sign Up RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up ➤ Sign Up RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up PFIZER INC. (New York, NY) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for LEUKINE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014 00047 Denmark ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140527
2014 00047 Denmark ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REG. NO/DATE: EU/1/14/928/001-002 20140522
14/048 Ireland ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
543 Luxembourg ➤ Sign Up PRODUCT NAME: SILTUXIMAB
14C/052 Belgium ➤ Sign Up PRODUCT NAME: SILTUXIMAB; AUTHORISATION NUMBER AND DATE: EU/1/14/928/001 20140527
00687 Netherlands ➤ Sign Up PRODUCT NAME: SILTUXIMAB; REGISTRATION NO/DATE: EU/1/14/928/001-002 20140522
0140027 00115 Estonia ➤ Sign Up PRODUCT NAME: SILTUKSIMAB;REG NO/DATE: K(2014)3557 (LOPLIK) 27.05.2014
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
US Army
QuintilesIMS
Express Scripts
US Department of Justice
Julphar
Covington
Cipla
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.